“The initial vision was always to develop new therapeutics to help patients especially for diseases that there were no treatments for, some of the more intractable diseases that pharmaceutical companies haven’t figured out a cure for. That has been the main mission, and it still is. That is where the underlying mission is.”
Today, the demand for technology capable of analyzing proteins at faster rates for drug discovery has never been more pressing. This is where companies can make a direct impact. ImmutoScientific serves as a transformative platform poised to revolutionize drug discovery and therapeutic development with cutting edge technology. With a mission to serve humanity, ImmutoScientific initially supported various companies with their drug discovery programs, leveraging their technology to validate their expertise and gain brand attention from major pharmaceutical entities.
After a year and a half of dedication, ImmutoScientific became fully validated in both the commercial and technical space and are beginning their own drug discovery efforts. Behind the groundbreaking work of this company are co-founders Faraz Choudhury (serving as CEO) and Dan Benjamin (serving as CTO), both Ph.D.s in electrical engineering who met as they both worked for the same Engineering lab at UW Madison.
Read more here: https://business.wisc.edu/centers/weinert/blog/alumni-spotlight-immutoscientific/